LIPOPREDICT: Previsão da resposta dos pacientes a fármacos antineoplásicos lipossomais: focando na atividade endocítica do LRP1B
Team
Sponsor
FCT
Dates and Lifetime
From: 2018-07-15 To: 2022-01-14
Duration: 42 months
Reference
POCI-01-0145-FEDER-031520
Code
LIPOPREDICT